Topical and systemic treatment of psoriasis using 7-chloro-N-(3,4-dichlorophenyl)-2,3-dihydro-5-hydroxy-1-benzothiepin-4-carboxamide 1,1-dioxide and pharmaceutically acceptable salts thereof

摘要

Psoriasis is treated by the topical or oral administration of an effective endogenous lipoxygenase inhibiting amount of a compound of the formula <IMAGE> (I) and the pharmaceutically acceptable salts thereof to a patient in need of the same.